FDA Drug Application (019046) for NORMOZIDE by SCHERING

Back to FDA Applications sponsored by SCHERING

Application Number019046
Product Number001
FormTABLET;ORAL
Dosage25MG;100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNORMOZIDE
Active IngredientHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient LABETALOL HYDROCHLORIDE5


Back to FDA Applications sponsored by SCHERING